Federal contractor · NEW HAVEN, CT

L2 DIAGNOSTICS LLC

No contract obligations recorded for L2 DIAGNOSTICS LLC in FY2026. Since FY2017: $3M. Its largest customer was National Institutes of Health ($0). It also received $1.2M in federal grants and other assistance in FY2026.

Obligations · FY2026
$0
New awards
1
Sole-source
—
Single offer
—
UEI
GKA7VH5LFR25
Parent company
L2 DIAGNOSTICS LLC
Small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 2MFY2017
  2. 55KFY2018
  3. 0FY2019
  4. 899.5KFY2025
  5. 0FY2026

Top buying agencies

Obligations in FY2026.

  1. National Institutes of Health$00.0%
    1 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Largest awards

  1. THERAPEUTIC VACCINE PLATFORM TO BOOST IMMUNE RESPONSES IN TUBERCULOSIS$599.5K
    National Institutes of Health· South Central Connecticut Planning Region, CT· Research & development· Jul 28, 2025 – Jul 22, 2026· 75N93025C00024

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

L2 DIAGNOSTICS LLC received $1.2M in federal assistance in FY2026, on 10 actions (1 new awards), −50% vs FY2025. Its largest program was 93.855 · Allergy and Infectious Diseases Research ($874.8K).

Assistance · FY2026
$1.2M
New awards
1
Actions
10
Since FY2021
$10M

Assistance by fiscal year

  1. 1.3MFY2021
  2. 2MFY2022
  3. 979.5KFY2023
  4. 2.2MFY2024
  5. 2.4MFY2025
  6. 1.2MFY2026

By type

  1. Grants$1.2M100%

Top programs

  1. 93.855 · Allergy and Infectious Diseases Research$874.8K73%
  2. 93.846 · Arthritis, Musculoskeletal and Skin Diseases Research$323.1K27%

Awarding agencies

  1. National Institutes of Health$1.2M100%
    Department of Health and Human Services

Largest awards

  1. A NOVEL VACCINE AGAINST MOSQUITO-BORNE ZIKA VIRUS BASED ON MOSQUITO SALIVARY GLAND PROTEIN AGBR1 - SUMMARY ARBOVIRUSES PRESENT A CONSTANT…$2.9M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Aug 18, 2022 – Dec 10, 2025· R42AI142846
  2. PFAG, A MULTIVALENT PEPTIDE VACCINE AGAINST MALARIA - ABSTRACT PFAG IS OUR NOVEL MALARIA VACCINE, COMPOSED OF SHORT SYNTHETIC PEPTIDES…$600K
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Sep 15, 2025 – Aug 28, 2026· R41AI195230
  3. THE MOSQUITO SALIVARY PROTEIN AGBR1 AS VACCINE CANDIDATE AGAINST CHIKUNGUNYA - PROJECT SUMMARY CHIKUNGUNYA IS AN ARBOVIRAL DISEASE…$599.9K
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Jul 17, 2024 – May 18, 2026· R41AI186794
  4. A NOVEL THERAPEUTIC FOR LYME ARTHRITIS BASED ON A SECRETORY LEUKOCYTE PROTEASE INHIBITOR - PROJECT SUMMARY/ABSTRACT LYME DISEASE (LD), THE…$599.9K
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Jul 8, 2024 – May 18, 2026· R41AI186833
  5. DELIVERY OF A CANDIDATE AGTRIOVX MALARIA VACCINE BY THERMOSTABLE MICRONEEDLE PATCHES - ABSTRACT MALARIA REMAINS ONE OF THE DEADLIEST…$599.7K
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· May 28, 2024 – Mar 16, 2026· R41AI184218
  6. A VACCINE TARGETING MOSQUITO METABOLIC PATHWAYS TO ERADICATE MALARIA - ABSTRACT THE WORLD HEALTH ORGANIZATION, NIH/NIAID, AND OTHER PUBLIC…$599.7K
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Sep 23, 2025 – Aug 14, 2026· R41AI195232

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026 · FY2021–FY2026.

Subawards

Matched by Unique Entity ID: the first-tier subawards this organization reported as a prime recipient, and those primes reported paying it.

As a prime: who it pays · FY2026

No subawards reported as a prime in FY2026.

As a sub-recipient: who pays it · FY2026

No subawards reported to it in FY2026.

By fiscal year

  • FY2021: $0 paid out · $222.4K received
  • FY2022: $0 paid out · $619.4K received
  • FY2023: $0 paid out · $221.4K received
  • FY2024: $0 paid out · $216.7K received

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 3, 2026, loaded Oct 3, 2026 · Subawards loaded from FY2021.

Teaming partners

Companies this company reported paying, primes that reported paying it, from FFATA subaward reports.

Companies it pays

No subawards reported to other companies.

Primes that pay it

2 companies · $1.3M reported

  1. UNIVERSITY OF ALABAMA AT BIRMINGHAM$848.6K
    BIRMINGHAM, AL · 5 subawards
  2. YALE UNIV$431.4K
    NEW HAVEN, CT · 1 subaward

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 3, 2026, loaded Oct 3, 2026 · Subawards loaded from 2021.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. THE BRAIN DONOR PROJECT, INC$999.1K+79% in FY2026
    NAPLES, FL · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  2. GENOMIC LABS LTD$1M−100% in FY2026
    BRISTOL, GBR · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  3. BENUVIA OPERATIONS, LLC$789.9K−100% in FY2026
    ROUND ROCK, TX · 88% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026.